Zhiguang Su
State Key Laboratory Of Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
RACGAP1 defines a malignant proliferative niche and represents a therapeutic vulnerability in lung adenocarcinoma.
Journal: Translational lung cancer research
Published: October 10, 2025
Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets.
Journal: Chinese medical journal
Published: June 07, 2025
A multi-omics Mendelian randomization study reveals PAM as a potential therapeutic target for type 2 diabetes.
Journal: Journal of translational medicine
Published: May 30, 2025
Cholesterol Sulfate: Pathophysiological Implications and Potential Therapeutics.
Journal: Biomolecules
Published: March 10, 2025
Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets.
Journal: Molecular biomedicine
Published: September 01, 2024
From stem cells to pancreatic β-cells: strategies, applications, and potential treatments for diabetes.
Journal: Molecular and cellular biochemistry
Published: January 16, 2024
Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.
Journal: Chinese medical journal
Published: October 13, 2023
JunB condensation attenuates vascular endothelial damage under hyperglycemic condition.
Journal: Journal of molecular cell biology
Published: May 20, 2023
Nuclear factor-Y mediates pancreatic β-cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress.
Journal: Chinese medical journal
Published: September 26, 2022
Last Updated: 09/26/2026